You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 107 No. 8, August 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (65)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Epidemiology of Ocular Herpes Simplex

Natural History in Rochester, Minn, 1950 Through 1982

Thomas J. Liesegang, MD

Arch Ophthalmol. 1989;107(8):1160-1165.


Abstract

• In the period 1950 through 1982, there were 294 episodes of ocular herpes simplex virus infection in 151 residents of Rochester, Minn. Recurrence rates assessed by life-table methods after the first episode were 9.6% at 1 year, 22.9% at 2 years, and 63.2% at 20 years. Recurrence rates appeared to rise following repeated episodes. Ocular herpes simplex affecting both eyes at the same and/or different episodes was seen in 18 patients (11.9%). One fifth of patients had lid involvement alone, while a third had solely superficial corneal involvement. Deep corneal disease or uveitis was relatively uncommon. Therapy during the early period was varied, but significant complications were uncommon. Ninety percent of the eyes maintained visual acuity of 20/40 or better. The economic impact, measured in terms of days of active disease and physician visits, was substantial.



Author Affiliations

From the Department of Ophthalmology, Mayo Clinic, Rochester, Minn.


Footnotes

Accepted for publication February 27, 1989.

Portions of this work were submitted as a candidate thesis for membership in the American Ophthalmological Society and accepted by the committee on theses.

Reprint requests to the Division of Ophthalmology, Mayo Clinic Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 (Dr Liesegang).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Topical Bevacizumab in the Treatment of Corneal Neovascularization: Results of a Prospective, Open-Label, Noncomparative Study
Dastjerdi et al.
Arch Ophthalmol 2009;127:381-389.
ABSTRACT | FULL TEXT  

Effective Treatment of Ocular HSK with a Human Apolipoprotein E Mimetic Peptide in a Mouse Eye Model
Bhattacharjee et al.
IOVS 2008;49:4263-4268.
ABSTRACT | FULL TEXT  

Herpes Zoster Ophthalmicus in Olmsted County, Minnesota: Have Systemic Antivirals Made a Difference?
Severson et al.
Arch Ophthalmol 2003;121:386-390.
ABSTRACT | FULL TEXT  

Bilateral Periorbital Eruption in an Immunocompromised Host--Diagnosis
Arch Dermatol 2003;139:215-220.
FULL TEXT  

Primary herpes simplex virus type 1 infection of the eye triggers similar immune responses in the cornea and the skin of the eyelids
Stumpf et al.
J. Gen. Virol. 2002;83:1579-1590.
ABSTRACT | FULL TEXT  

Herpes Simplex Virus Type 1 Entry Is Inhibited by the Cobalt Chelate Complex CTC-96
Schwartz et al.
J. Virol. 2001;75:4117-4128.
ABSTRACT | FULL TEXT  

Tegument-Specific, Virus-Reactive CD4 T Cells Localize to the Cornea in Herpes Simplex Virus Interstitial Keratitis in Humans
Koelle et al.
J. Virol. 2000;74:10930-10938.
ABSTRACT | FULL TEXT  

Psychological Stress and Other Potential Triggers for Recurrences of Herpes Simplex Virus Eye Infections
Herpetic Eye Disease Study Group
Arch Ophthalmol 2000;118:1617-1625.
ABSTRACT | FULL TEXT  

Oral Acyclovir Suppresses Recurrent Epithelial and Stromal Herpes Simplex
Langston
Arch Ophthalmol 1999;117:391-392.
FULL TEXT  

Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease
Wilhelmus et al.
NEJM 1998;339:300-306.
ABSTRACT | FULL TEXT  

Acyclovir for Recurrent Herpes Simplex Virus Ocular Disease
Jabs
NEJM 1998;339:340-341.
FULL TEXT  

A Controlled Trial of Oral Acyclovir for the Prevention of Stromal Keratitis or Iritis in Patients With Herpes Simplex Virus Epithelial Keratitis: The Epithelial Keratitis Trial
The Herpetic Eye Disease Study Group
Arch Ophthalmol 1997;115:703-712.
ABSTRACT  

A Controlled Trial of Oral Acyclovir for Iridocyclitis Caused by Herpes Simplex Virus
The Herpetic Eye Disease Study Group
Arch Ophthalmol 1996;114:1065-1072.
ABSTRACT  

Recurrent Herpes Simplex Keratitis With Concurrent Epithelial and Stromal Involvement: Immunohistochemical and Ultrastructural Observations
Holbach et al.
Arch Ophthalmol 1991;109:692-695.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.